TYGACIL PASS, Final Protocol Amendment 2 dated 08 Nov 12

• Research type

  Research Study

• Full title

  Non-Interventional Post-Authorization Safety Study to Describe Use by Indication and Clinical Outcomes Among Patients with Complicated Intra-Abdominal Infection or Complicated Skin and Soft Tissue Infection Treated with Tigecycline (Tygacil®) in the European Union.

• IRAS ID

  127905

• Contact name

  Andrew Kirby

• Contact email

  Andrew.Kirby@leedsth.nhs.uk

• Sponsor organisation

  Pfizer, Inc.

• REC name

  Yorkshire & The Humber - South Yorkshire Research Ethics Committee

• REC reference

  13/YH/0094

• Date of REC Opinion

  3 May 2013

• REC opinion

  Favourable Opinion